Last edition
News about Consultants
FDA Approves Drug to Treat Infants and Children with HIV
Today, the U.S. Food and Drug Administration approved Tivicay (dolutegravir) tablets and Tivicay PD (dolutegravir) tablets for suspension to treat HIV-1 infection in pediatric patients at least four weeks old and weighing at least 3 kg (6.61 pounds) in combination with other antiretroviral treatments
Consultants | 15/06/2020 | By Darshana | 389
Coronavirus: WHO stops trial of hydroxycloroquine due to safety concerns
The World Health Organization has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to safety concerns, WHO Director General Tedros Adhanom Ghebreyesus said on Monday
Consultants | 26/05/2020 | By Darshana | 471
DRDO introduces two new products to enhance operations during COVID-19 disinfection process
The Defence Research and Development Organisation (DRDO) has introduced two products which can enhance the operations at public places during the COVID-19 disinfection process
Consultants | 19/04/2020 | By Darshana | 351
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy